RecruitingNot ApplicableNCT05535192

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients (THRIVE-65)


Sponsor

Dana-Farber Cancer Institute

Enrollment

270 participants

Start Date

Mar 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to schedule and at the planned dose.


Eligibility

Sex: FEMALEMin Age: 65 Years

Inclusion Criteria8

  • Women age \>=65
  • Diagnosed with stage I-III invasive breast cancer
  • BMI between 18-50 kg/m2
  • Scheduled to begin at least 10 weeks of neoadjuvant or adjuvant cytotoxic chemotherapy for curative intent
  • If enrolled in clinical chemotherapy drug trial, considered eligible if regimen includes an anthracycline or a taxane, unless the trial alters the chemotherapy agents/doses according to patient response (e.g.; I-SPY trials)
  • Self-reported ability to walk for 6 minutes and/or 2 blocks (with or without assistive device)
  • Ability to provide written informed consent.
  • Ability to understand, speak, and read English. This is because many of the study instruments used are not readily available in multiple languages. Additionally, site-based study staff, such as exercise physiologists, are not bilingual and not all sites have access to interpreters.

Exclusion Criteria7

  • Following a therapeutic diet for co-morbid disease where the THRIVE-65 diet would be contraindicated as assessed by the RD
  • Engaging in 2 or more sessions of strength training exercise per week over a period of at least 3 consecutive months over the past year
  • Engaging in aerobic activity at a level that includes competitive events (e.g., marathon, triathlon, running races) over the past year
  • Presence of medical conditions or medications that would prohibit participation in an exercise program
  • Current use of weight-loss medication
  • Documented history of alcohol or substance abuse within the past 12 months
  • History of dementia

Interventions

BEHAVIORALTHRIVE

The THRIVE Intervention will involve: 1\) one in-person exercise sessions, followed by twice-weekly, home-based exercise sessions, supervised remotely through telehealth, and 2) a remotely delivered dietary assessment and recommendations to support protein intake throughout the study

BEHAVIORALHealth Education Support Program

Participants will receive a tablet with information and resources regarding mediation, stretching and gentle movement, relaxation and creative arts during chemotherapy


Locations(3)

Dana Farber Cancer Institute

Boston, Massachusetts, United States

Case Western Reserve University/University Hospitals Cleveland

Cleveland, Ohio, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05535192


Related Trials